Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer? Editorial Article uri icon

Overview

publication date

  • May 3, 2009

Research

keywords

  • Adjuvants, Immunologic
  • Antibiotics, Antineoplastic
  • BCG Vaccine
  • Mitomycin
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 67649444342

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2009.04.041

PubMed ID

  • 19427109

Additional Document Info

volume

  • 56

issue

  • 2